Literature DB >> 30259520

Safety of rectum anastomosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Philipp von Breitenbuch1,2, Pompiliu Piso3, Hans J Schlitt1.   

Abstract

BACKGROUND AND OBJECTIVES: In highly selected patients with peritoneal carcinomatosis, cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can be an aggressive but worthwhile treatment regimen. Resection of the rectosigmoid is frequently performed with CRS. The aim of the study was to assess the safety of the rectal anastomosis in this setting.
METHODS: Between 2005 and 2016, 436 patients underwent CRS/HIPEC. Clinical data were analyzed with respect to the morbidity associated with a rectum resection.
RESULTS: In 436 patients, 174 rectum resections (40%) were performed with CRS, including 149 anterior resections of the rectosigmoid, 23 low anterior rectum resections, and 2 abdominoperineal rectum excisions. A total of 141 rectum anastomoses were performed; 33 patients received a permanent ostomy, and 48 patients received a protective ileostomy. After changing the operation technique of the rectum anastomosis, the number of protective ileostomies decreased from 65% to 20%. The overall postoperative morbidity was 31%. Rectal anastomotic leakages were seen in only 5% of cases.
CONCLUSIONS: Anastomotic leakages of the rectum are rarely seen after CRS/HIPEC. HIPEC performed immediately after surgery seems to have no negative effect on the rectum anastomosis. Performing rectum anastomoses after CRS/ HIPEC appears to be a safe procedure.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cytoreduction; peritoneal carcinomatosis (PC); rectum resection

Mesh:

Year:  2018        PMID: 30259520     DOI: 10.1002/jso.25189

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Is platelet-rich plasma improves the anastomotic healing in hyperthermic intraperitoneal chemotherapy with oxaliplatin: an experimental rat study.

Authors:  Omer Faruk Buk; Sonmez Ocak; Bugra Genc; Bahattin Avcı; Hatice Olger Uzuner
Journal:  Ann Surg Treat Res       Date:  2020-01-31       Impact factor: 1.859

2.  Safety of coloanal/ileoanal anastomosis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: results of 20 consecutive patients.

Authors:  Ozgul Duzgun; Murat Kalin
Journal:  J Int Med Res       Date:  2019-09-10       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.